Scientific article
Review
English

The rise of transplant oncology in primary liver cancer and metastatic disease

Published in

Hepatology, vol. 84, no. 4, p. 1181-1208

Publication date

2026-10-01

First online date

2026-02-25

Abstract

Background and aims: Liver transplantation has evolved from a treatment restricted to patients with end-stage liver disease to a therapeutic option for selected patients with primary and metastatic liver malignancies. This review explores the rapidly expanding field of transplant oncology, highlighting its role in hepatocellular carcinoma, colorectal liver metastasis, neuroendocrine liver metastasis, and intrahepatic and perihilar cholangiocarcinoma. Emphasis is placed on strategies to broaden eligibility, optimize donor organ use, and improve oncologic outcomes.

Approach and results: We synthesized current evidence from clinical series, registries, and experimental protocols to evaluate patient selection criteria, outcomes, and peri-transplant management. Key topics include downstaging approaches to meet transplant criteria, such as locoregional therapies and systemic regimens, and their prognostic implications. Advances in donor utilization have been analyzed for their capacity to expand the graft pool. In addition, the review addresses the integration of oncologic principles into immunosuppression regimens, balancing graft protection with cancer control. Collectively, the reported studies demonstrate improved survival and reduced recurrence when stringent selection and multimodal therapy were applied.

Conclusions: Transplant oncology reshapes the therapeutic landscape of liver malignancies, with growing evidence supporting liver transplantation in carefully selected patients beyond traditional indications. Optimized downstaging, innovative donor strategies, and tailored immunosuppression are pivotal for safe expansion. Continued collaboration between the transplant and oncology disciplines, along with prospective trials, is essential to further define standardized protocols and solidify transplantation as a cornerstone of multidisciplinary cancer care.

Keywords

  • Cholangiocarcinoma
  • Colorectal liver metastasis
  • Hepatocellular carcinoma
  • Immunosuppression
  • Liver transplantation
  • Neuroendocrine liver metastasis
  • Transplant oncology
  • Humans
  • Liver Transplantation / methods
  • Liver Neoplasms / surgery
  • Liver Neoplasms / secondary
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy
  • Carcinoma, Hepatocellular / surgery
  • Carcinoma, Hepatocellular / secondary
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Patient Selection
  • Cholangiocarcinoma / surgery
  • Bile Duct Neoplasms / surgery
  • Bile Duct Neoplasms / pathology
  • Neuroendocrine Tumors / secondary
  • Neuroendocrine Tumors / surgery
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / surgery

Citation (ISO format)

WASSMER, Charles-Henri et al. The rise of transplant oncology in primary liver cancer and metastatic disease. In: Hepatology, 2026, vol. 84, n° 4, p. 1181–1208. doi: 10.1097/HEP.0000000000001723

Main files (1)

Article (Published version)

Secondary files (1)

Appendix

Identifiers

Journal ISSN

0270-9139
1views
0downloads

Technical informations

Creation

18/11/2026 13:47:05

First validation

18/11/2026 13:54:12

Update

18/11/2026 13:54:12

Status update

18/11/2026 13:54:12

Last indexation

18/11/2026 13:54:14
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated